Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 2/20 | 0.33 |
| ▸ | HTR1A | P08908 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1656937 | 0.99 | ADRB2 (0.33) | ADRB2HTR1AALDH1A1PARP1BRD4 | |
| SCHEMBL559885 | 0.98 | ADRB2 (0.33) | ADRB2HTR1AALDH1A1PARP1BRD4 | |
| SCHEMBL12952231 | 0.96 | ADRB2 (0.32) | ADRB2HTR1AALDH1A1TBXA2RCYP26B1 | |
| SCHEMBL178258 | 0.95 | ALDH1A1 (0.32) | ADRB2HTR1AALDH1A1TBXA2RCYP26B1 | |
| SCHEMBL3239947 | 0.94 | ALDH1A1 (0.32) | ALDH1A1CYP26B1 | |
| SCHEMBL11912398 | 0.93 | ALDH1A1 (0.33) | ALDH1A1TBXA2RCYP26B1PKMP2RX3 | |
| SCHEMBL15227488 | 0.89 | ADRB2 (0.32) | ADRB2HTR1AALDH1A1PARP1BRD4 | |
| SCHEMBL1715480 | 0.89 | ADRB2 (0.32) | ADRB2HTR1AALDH1A1PARP1BRD4 | |
| SCHEMBL2065361 | 0.89 | ALDH1A1 (0.31) | ALDH1A1TBXA2RCYP26B1PKM | |
| SCHEMBL3239936 | 0.89 | ALDH1A1 (0.32) | ALDH1A1CYP26B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9110069-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2015-08-18 | — | — | US | disclosed |
| EP-2129788-B1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS LLC (US) | 2014-09-03 | — | — | EP | disclosed |
| US-20140086844-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC (US) | 2014-03-27 | — | — | US | disclosed |
| US-8642014-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2014-02-04 | — | — | US | disclosed |
| US-8552027-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2013-10-08 | — | — | US | disclosed |
| US-20120035346-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2012-02-09 | — | — | US | disclosed |
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2010-10-21 | — | — | US | disclosed |
| WO-2010083471-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC (US) | 2010-07-22 | — | — | WO | disclosed |
| US-7411068-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC | 2008-08-12 | — | — | US | disclosed |
| US-20070281363-A1 | Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence | Terpetschnig, Ewald (US) | 2007-12-06 | — | — | US | disclosed |
| US-7250517-B2 | Luminescent compounds | Terpetschnig, Ewald A. (US) | 2007-07-31 | — | — | US | disclosed |
| US-20050202565-A1 | Luminescent compounds | SETA BIOMEDICALS, LLC | 2005-09-15 | — | — | US | disclosed |
| US-20040166515-A1 | Luminescent compounds | TERPETSCHNIG, EWALD A. | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SQLE, COASY, ZKSCAN2 | ADRB2 3327/4885HTR1A 4607/4885ALDH1A1 2552/4885 |
| US-20140086844-A1 | LUMINESCENT COMPOUNDS | PHOSPHO1, PGLS, PFAS | ADRB2 2578/4885HTR1A 2621/4885ALDH1A1 2920/4885 |
| US-20120035346-A1 | LUMINESCENT COMPOUNDS | PHOSPHO1, PGLS, PFAS | ADRB2 2657/4885HTR1A 2926/4885ALDH1A1 2941/4885 |
| US-20040166515-A1 | Luminescent compounds | RORC, NR2E3, RORB | ADRB2 1824/4885HTR1A 3912/4885ALDH1A1 1924/4885 |
| US-20070281363-A1 | Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence | SPR, SRRT, SQLE | ADRB2 2417/4885HTR1A 4193/4885ALDH1A1 2350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.